Avalo Therapeutics (AVTX) Intangibles (2017 - 2021)
Avalo Therapeutics (AVTX) posted Intangibles of $38000.0 for Q4 2021, down 87.5% on a QoQ basis from $304000.0 in Q3 2021, and down 97.6% year-over-year from $1.6 million in Q4 2020.
Avalo Therapeutics (AVTX) Intangibles (2017 - 2021) Analysis & Trends
Avalo Therapeutics' Intangibles history runs 5 years deep, the most recent figure standing at $38000.0 for Q4 2021.
- Quarterly Intangibles fell 97.6% year-over-year to $38000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $38000.0 (down 97.6% YoY) and the FY2021 annual result came in at $38000.0, down 97.6% from the prior year.
- Intangibles was $38000.0 for Q4 2021 at Avalo Therapeutics, down from $304000.0 in the prior quarter.
- Across five years, Intangibles topped out at $33.1 million in Q1 2018 and bottomed at $38000.0 in Q4 2021.
- A 5-year average of $10.9 million and a median of $2.3 million in 2020 frame the typical range for Intangibles.
- Peak annual rise in Intangibles reached 29.0% in 2021, while the deepest fall reached 97.6% in 2021.
- Avalo Therapeutics' Intangibles stood at $17.7 million in 2017, then sank by 78.68% to $3.8 million in 2018, then tumbled by 35.57% to $2.4 million in 2019, then tumbled by 34.67% to $1.6 million in 2020, then tumbled by 97.6% to $38000.0 in 2021.
- Business Quant data shows AVTX's Intangibles at $38000.0 in Q4 2021, $304000.0 in Q3 2021, and $732000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 38,000.00 |
| Sep 30, 2021 | 304,000.00 |
| Jun 30, 2021 | 732,000.00 |
| Mar 31, 2021 | 1.16 Mn |
| Dec 31, 2020 | 1.59 Mn |
| Sep 30, 2020 | 1.89 Mn |
| Jun 30, 2020 | 2.29 Mn |
| Mar 31, 2020 | 900,000.00 |
| Dec 31, 2019 | 2.43 Mn |
| Sep 30, 2019 | 26.60 Mn |
| Jun 30, 2019 | 27.63 Mn |
| Mar 31, 2019 | 1.40 Mn |
| Dec 31, 2018 | 3.77 Mn |
| Sep 30, 2018 | 32.46 Mn |
| Jun 30, 2018 | 32.00 Mn |
| Mar 31, 2018 | 33.10 Mn |
| Dec 31, 2017 | 17.66 Mn |